Editorial: Tailoring immunotherapy in gastrointestinal cancer: the role of circulating factors

Stefano Ugel; Chiara Bazzichetto; Fabiana Conciatori

doi:10.3389/fonc.2023.1260183

Editorial: Tailoring immunotherapy in gastrointestinal cancer: the role of circulating factors

Front Oncol. 2023 Aug 8:13:1260183. doi: 10.3389/fonc.2023.1260183. eCollection 2023.

Authors

Stefano Ugel¹, Chiara Bazzichetto², Fabiana Conciatori²

Affiliations

¹ Immunology Section, Department of Medicine, School of Medicine and Surgery, University of Verona, Verona, Italy.
² Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

No abstract available

Keywords: biomarkers; cancer immunotherapy; gastrointestinal cancer; immune system; inflammation.

Publication types

Editorial

Grants and funding

This work was supported by Stefano Ugel grants of the Fondazione Italiana per la Ricerca sul Cancro (AIRC) (MFAG project: 21509), and PRIN program of Italian Ministry of University and Research (MUR, CUP: B38D19000140006), Fondazione Cariverona (ENACT project) and PNRR programs of the Italian MUR (Project “National Center for Gene Therapy and Drugs based on RNA Technology”, application code CN00000041, Mission 4, Component 2 Investment 1.4, funded from the European Union – NextGeneration EU, MUR Directorial Decree No. 1035 of 17 June 2022, CUP B33C22000630001). This work was also supported in part by Bando Interno Ricerca Corrente IRE 2021-2022 (FC).